Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/06/2876127/24180/en/Celldex-Reports-First-Quarter-2024-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2024/03/08/2843022/24180/en/Celldex-Therapeutics-to-Participate-in-the-Leerink-Partners-Global-Biopharma-Conference.html
https://www.globenewswire.com//news-release/2024/03/05/2840644/24180/en/Celldex-Therapeutics-to-Present-at-TD-Cowen-s-44th-Annual-Health-Care-Conference.html
https://www.globenewswire.com//news-release/2024/03/05/2840626/24180/en/Celldex-Therapeutics-Announces-Closing-of-Public-Offering-of-Common-Stock-and-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares.html
https://finance.yahoo.com/news/celldex-therapeutics-present-td-cowen-153000836.html
https://ir.celldex.com/news-releases/news-release-details/celldex-therapeutics-announces-pricing-upsized-400-million
https://www.globenewswire.com//news-release/2024/02/28/2837393/24180/en/Celldex-Therapeutics-Announces-Proposed-Public-Offering-of-Common-Stock.html
https://endpts.com/celldexs-csu-drug-could-challenge-a-novartis-candidate-after-phii/
https://www.globenewswire.com//news-release/2024/02/26/2835014/24180/en/Celldex-Reports-Fourth-Quarter-and-Year-End-2023-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2024/02/24/2834744/24180/en/Celldex-Therapeutics-Presents-Positive-12-Week-Results-from-Barzolvolimab-Phase-2-Study-in-Chronic-Spontaneous-Urticaria.html